Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Assunta Rocca

Showing results (51-60 of 76) with videos related to

Pageof 8
Sort By:
European Journal of Neurology|May 25, 2023
Ocrelizumab extended-interval dosing in multiple sclerosis during SARS-CoV-2 pandemic: a real-world experienceSimone Guerrieri, Chiara Bucca, Agostino Nozzolillo, et al.
Human Brain Mapping|October 18, 2022
Prediction of the information processing speed performance in multiple sclerosis using a machine learning approach in a large multicenter magnetic resonance imaging data setChiara Marzi, Alessandro d'Ambrosio, Stefano Diciotti, et al.
Journal of Neurology|October 25, 2017
Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsing-remitting multiple sclerosis: an 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study)Giancarlo Comi, Francesco Patti, Maria Assunta Rocca, et al.
Journal of Neurology|May 13, 2026
Ocrelizumab in early relapsing-remitting multiple sclerosis: first interim analysis of the MUSPO Italian prospective cohortMassimo Filippi, Emanuele D'Amico, Vincenzo Brescia Morra, et al.
Journal of Neurology|August 7, 2023
The effect of erenumab on brain network function in episodic migraine patients: a randomized, placebo-controlled clinical trial (RESET BRAIN)Massimo Filippi, Roberta Messina, Marta Bartezaghi, et al.
Neurology|December 11, 2012
Location of brain lesions predicts conversion of clinically isolated syndromes to multiple sclerosisAntonio Giorgio, Marco Battaglini, Maria Assunta Rocca, et al.
BMC Neurology|May 24, 2020
Study protocol: improving cognition in people with progressive multiple sclerosis: a multi-arm, randomized, blinded, sham-controlled trial of cognitive rehabilitation and aerobic exercise (COGEx)Anthony Feinstein, Maria Pia Amato, Giampaolo Brichetto, et al.
Brain : a Journal of Neurology|January 24, 2024
Time is myelin: early cortical myelin repair prevents atrophy and clinical progression in multiple sclerosisAndrea Lazzarotto, Mariem Hamzaoui, Matteo Tonietto, et al.
Journal of the Neurological Sciences|February 18, 2025
Effects of rhythmic-cued gait training on gait-like task related brain activation in people with multiple sclerosisBirgit Helmlinger, Barbara Seebacher, Stefan Ropele, et al.
Journal of Neurology|November 6, 2021
The impact of the COVID-19 pandemic on an international rehabilitation study in MS: the CogEx experienceAnthony Feinstein, Maria Pia Amato, Giampaolo Brichetto, et al.
Pageof 8

Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
European Journal of Neurology|May 25, 2023
Ocrelizumab extended-interval dosing in multiple sclerosis during SARS-CoV-2 pandemic: a real-world experienceSimone Guerrieri, Chiara Bucca, Agostino Nozzolillo, et al.
Human Brain Mapping|October 18, 2022
Prediction of the information processing speed performance in multiple sclerosis using a machine learning approach in a large multicenter magnetic resonance imaging data setChiara Marzi, Alessandro d'Ambrosio, Stefano Diciotti, et al.
Journal of Neurology|October 25, 2017
Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsing-remitting multiple sclerosis: an 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study)Giancarlo Comi, Francesco Patti, Maria Assunta Rocca, et al.
Journal of Neurology|May 13, 2026
Ocrelizumab in early relapsing-remitting multiple sclerosis: first interim analysis of the MUSPO Italian prospective cohortMassimo Filippi, Emanuele D'Amico, Vincenzo Brescia Morra, et al.
Journal of Neurology|August 7, 2023
The effect of erenumab on brain network function in episodic migraine patients: a randomized, placebo-controlled clinical trial (RESET BRAIN)Massimo Filippi, Roberta Messina, Marta Bartezaghi, et al.
Neurology|December 11, 2012
Location of brain lesions predicts conversion of clinically isolated syndromes to multiple sclerosisAntonio Giorgio, Marco Battaglini, Maria Assunta Rocca, et al.
BMC Neurology|May 24, 2020
Study protocol: improving cognition in people with progressive multiple sclerosis: a multi-arm, randomized, blinded, sham-controlled trial of cognitive rehabilitation and aerobic exercise (COGEx)Anthony Feinstein, Maria Pia Amato, Giampaolo Brichetto, et al.
Brain : a Journal of Neurology|January 24, 2024
Time is myelin: early cortical myelin repair prevents atrophy and clinical progression in multiple sclerosisAndrea Lazzarotto, Mariem Hamzaoui, Matteo Tonietto, et al.
Journal of the Neurological Sciences|February 18, 2025
Effects of rhythmic-cued gait training on gait-like task related brain activation in people with multiple sclerosisBirgit Helmlinger, Barbara Seebacher, Stefan Ropele, et al.
Journal of Neurology|November 6, 2021
The impact of the COVID-19 pandemic on an international rehabilitation study in MS: the CogEx experienceAnthony Feinstein, Maria Pia Amato, Giampaolo Brichetto, et al.
Pageof 8